Dear friends of ocular proton therapy,
we are happy to announce the second PTCOG ocular online webinar:
Ocular Proton Therapy at MedAustron using a non-dedicated beamline
At the EBG MedAustron the clinical treatment of ocular tumors started at the end of 2024. An in house development of a medical device accessory according to the MDR allows the treatment with a non-dedicated beamline in a multipurpose treatment room. With the modifications to the nozzle it was possible to achieve similar dosimetric quality as dedicated ocular proton centers utilizing a low energy cyclotron. A dedicated clinical workflow in RayStation 2024A including the RayOcular module was developed for precise target definition and in room positioning, based on a combination of a structure- and image based planning approach. High data density is achieved by integrating CT, MR and fundus images as well as surgery and US measurement data. Treatment is performed on 4 consecutive days with 15Gy/fr with a mean in room time of 40 minutes per patient.
Presented by Patrick Scharpf-Roisl
Medical Physicist at the EBG MedAustron in Wr. Neustadt, Austria. Started at MedAustron in 2020 as project lead to implement the non-dedicated ocular beamline and slowly transferred from system development and CE certification towards clinical implementation. Aside from ocular proton therapy, treatment planning with protons and carbons, TPS commissioning, end-to-end testing, PSQA and MDR topics are part of his area of responsibility.
Due to registration issues with the previous webinar, we have simplified the process. No registration is required. The webinar link is available in the menu on the left. Simply click the link to join the meeting.
Feel free to share the link with anyone who may find the webinar relevant.
